These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1875952)

  • 1. Inhibitors of membrane lipid metabolism enhance complement-mediated nucleated cell killing through distinct mechanisms.
    Papadimitriou JC; Carney DF; Shin ML
    Mol Immunol; 1991 Aug; 28(8):803-9. PubMed ID: 1875952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of terminal complement complexes in the plasma membrane of nucleated cells: influence of extracellular Ca2+ and association with cellular Ca2+.
    Carney DF; Hammer CH; Shin ML
    J Immunol; 1986 Jul; 137(1):263-70. PubMed ID: 3711667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleated cell killing by complement: effects of C5b-9 channel size and extracellular Ca2+ on the lytic process.
    Kim SH; Carney DF; Hammer CH; Shin ML
    J Immunol; 1987 Mar; 138(5):1530-6. PubMed ID: 2433349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.
    Milis L; Morris CA; Sheehan MC; Charlesworth JA; Pussell BA
    Clin Exp Immunol; 1993 Apr; 92(1):114-9. PubMed ID: 7682159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytolysis of nucleated cells by complement: inhibition of membrane-transmethylation enhances cell death by C5b-9.
    Hänsch GM; Betz M; Shin ML
    J Immunol; 1984 Mar; 132(3):1440-4. PubMed ID: 6693772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of terminal complement intermediates from the plasma membrane of nucleated cells: the rate of disappearance differs for cells carrying C5b-7 or C5b-8 or a mixture of C5b-8 with a limited number of C5b-9.
    Carney DF; Koski CL; Shin ML
    J Immunol; 1985 Mar; 134(3):1804-9. PubMed ID: 3968432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of prostanoid synthesis in human platelets by the late complement components C5b-9 and channel forming antibiotic nystatin: inhibition of the reacylation of liberated arachidonic acid.
    Hänsch GM; Gemsa D; Resch K
    J Immunol; 1985 Aug; 135(2):1320-4. PubMed ID: 2409145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of osmotic protection on nucleated cell killing by C5b-9: cell death is not affected by the prevention of cell swelling.
    Kim SH; Carney DF; Papadimitriou JC; Shin ML
    Mol Immunol; 1989 Mar; 26(3):323-31. PubMed ID: 2468081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane attack complex of complement: generation of high-affinity phospholipid binding sites by fusion of five hydrophilic plasma proteins.
    Podack ER; Biesecker G; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):897-901. PubMed ID: 284414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of the terminal complement complex on agarose beads: further evidence that vitronectin (complement S-protein) inhibits C9 polymerization.
    Johnson E; Berge V; Høgåsen K
    Scand J Immunol; 1994 Mar; 39(3):281-5. PubMed ID: 7510414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins.
    Rosenfeld SI; Packman CH; Leddy JP
    J Clin Invest; 1983 Apr; 71(4):795-808. PubMed ID: 6403580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement lysis of U937, a nucleated mammalian cell line in the absence of C9: effect of C9 on C5b-8 mediated cell lysis.
    Morgan BP; Imagawa DK; Dankert JR; Ramm LE
    J Immunol; 1986 May; 136(9):3402-6. PubMed ID: 3514758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killing of human melanoma cells by the membrane attack complex of human complement as a function of its molecular composition.
    Martin DE; Chiu FJ; Gigli I; Müller-Eberhard HJ
    J Clin Invest; 1987 Jul; 80(1):226-33. PubMed ID: 3597774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple signal messengers generated by terminal complement complexes and their role in terminal complement complex elimination.
    Carney DF; Lang TJ; Shin ML
    J Immunol; 1990 Jul; 145(2):623-9. PubMed ID: 2164064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Channel fluctuations induced by membrane attack complex C5B-9.
    Young JD; Young TM
    Mol Immunol; 1990 Oct; 27(10):1001-7. PubMed ID: 1700284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of complement C5b-9 binding to cells by flow cytometry.
    Moskovich O; Fishelson Z
    Methods Mol Biol; 2014; 1100():103-8. PubMed ID: 24218253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9.
    Farkas I; Baranyi L; Ishikawa Y; Okada N; Bohata C; Budai D; Fukuda A; Imai M; Okada H
    J Physiol; 2002 Mar; 539(Pt 2):537-45. PubMed ID: 11882685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a two-domain structure of the terminal membrane C5b-9 complex of human complement.
    Bhakdi S; Tranum-Jensen J
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5872-6. PubMed ID: 293689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimeric C9 within C5b-9 is required for inner membrane damage to Escherichia coli J5 during complement killing.
    Bloch EF; Schmetz MA; Foulds J; Hammer CH; Frank MM; Joiner KA
    J Immunol; 1987 Feb; 138(3):842-8. PubMed ID: 3100618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of membrane transmethylation reactions prevent the lymphocyte chemokinetic response.
    McFadden RG; Fraher LJ
    Immunol Lett; 1990 Dec; 26(3):211-5. PubMed ID: 2086448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.